Fig. 4.

Mean reduction in TCS between baseline and week 4 on DTT and other areas (LOCF): FAS. All lower-leg sites were considered as DTT areas, except for six sites on two patients, which were not on the anterior face of the tibia. BD betamethasone as dipropionate 0.5 mg/g, Cal calcipotriol 50 µg/g, BV betamethasone 17-valerate 2.25 mg, DTT difficult-to-treat, FAS full analysis set, LOCF last observation carried forward, TCS total clinical score